Pharmacogenetics, Drug-Metabolizing Enzymes, and Clinical Practice

@article{Gardiner2006PharmacogeneticsDE,
  title={Pharmacogenetics, Drug-Metabolizing Enzymes, and Clinical Practice},
  author={S. Gardiner and E. Begg},
  journal={Pharmacological Reviews},
  year={2006},
  volume={58},
  pages={521 - 590}
}
  • S. Gardiner, E. Begg
  • Published 2006
  • Medicine
  • Pharmacological Reviews
  • The application of pharmacogenetics holds great promise for individualized therapy. However, it has little clinical reality at present, despite many claims. The main problem is that the evidence base supporting genetic testing before therapy is weak. The pharmacology of the drugs subject to inherited variability in metabolism is often complex. Few have simple or single pathways of elimination. Some have active metabolites or enantiomers with different activities and pathways of elimination… CONTINUE READING
    373 Citations

    Figures, Tables, and Topics from this paper

    Review: Pharmacogenetic aspects of the effect of cytochrome P450 polymorphisms on serotonergic drug metabolism, response, interactions, and adverse effects
    • 56
    • Highly Influenced
    Pharmacogenomics and adverse drug reactions in diagnostic and clinical practice
    • 26
    GENETICS/GENOMICS AND DRUG EFFECTS
    • F. Heller
    • Medicine, Biology
    • Acta clinica Belgica
    • 2013
    • 10
    The role of pharmacogenetics in nonmalignant gastrointestinal diseases
    • M. Camilleri
    • Medicine
    • Nature Reviews Gastroenterology &Hepatology
    • 2012
    • 8

    References

    SHOWING 1-10 OF 1,094 REFERENCES
    Pharmacogenetic testing for drug metabolizing enzymes: is it happening in practice?
    • 81
    The future prospects of pharmacogenetics in oral anticoagulation therapy.
    • 58
    Inheritance and drug response.
    • 950
    • PDF
    Pharmacogenetics of cytochrome P4502D6: genetic background and clinical implication
    • I. Cascorbi
    • Medicine
    • European journal of clinical investigation
    • 2003
    • 196
    Pharmacokinetics of Voriconazole and Cytochrome p450 2C19 Genetic Status
    • 155
    Pharmacogenetics of Warfarin Elimination and its Clinical Implications
    • 311
    Cancer pharmacogenomics: achievements in basic research
    • 8
    Clinical Consequences of Cytochrome P450 2C9 Polymorphisms
    • 451